327065-78-1

Basic information

• Product Name: N,N'-bis(4-cyanophenyl)pentanediamide
• Synonyms: N,N'-bis(4-cyanophenyl)pentanediamide
• CAS NO: 327065-78-1
• Molecular Formula: C₁₉H₁₆N₄O₂
• Molecular Weight: 332.35594
• Mol File: 327065-78-1.mol

Chemical Properties

• Melting Point: 238-239 °C
• Boiling Point: 701.2±55.0 °C(Predicted)
• Appearance: /
• Density: 1.27±0.1 g/cm3(Predicted)
• PKA: 13.47±0.70(Predicted)
• CAS DataBase Reference: N,N'-bis(4-cyanophenyl)pentanediamide(CAS DataBase Reference)
• NIST Chemistry Reference: N,N'-bis(4-cyanophenyl)pentanediamide(327065-78-1)
• EPA Substance Registry System: N,N'-bis(4-cyanophenyl)pentanediamide(327065-78-1)

Safety Data

• Hazardous Substances Data: 327065-78-1(Hazardous Substances Data)

Upstream product

• 2873-74-7 gloutaric dichloride 
• 873-74-5 4-Aminobenzonitrile 

Downstream Products

• 1032470-70-4 N¹,N⁵-bis[4-(N'-hydroxycarbamimidoyl)phenyl]glutaramide 
• 1032470-76-0 N¹,N⁵-bis[4-(5-propyl-1,2,4-oxadiazol-3-yl)phenyl]glutaramide 
• 1032470-78-2 N¹,N⁵-bis[4-(5-pentyl-1,2,4-oxadiazol-3-yl)phenyl]glutaramide 
• 1032470-83-9 N¹,N⁵-bis[4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenyl]glutaramide 
• 1032470-84-0 N¹,N⁵-bis[4-(1,2,4-oxadiazol-3-yl)phenyl]glutaramide 
• 1032470-85-1 N¹,N⁵-bis{[4-(5-oxo-4,5-dihydro)-1,2,4-oxadiazol-3-yl]phenyl}glutaramide 
• 1032470-71-5 N¹,N⁵-bis[4-(N'-acetoxycarbamimidoyl)phenyl]glutaramide 
• 1032470-73-7 N¹,N⁵-bis{4-[N'-(butyryloxy)carbamimidoyl]phenyl}glutaramide 
• 1032470-77-1 N¹,N⁵-bis{4-[N'-(hexanoyloxy)carbamimidoyl]phenyl}glutaramide 
• 1032470-81-7 N¹,N⁵-bis{4-[N'-(benzoyloxy)carbamimidoyl]phenyl}glutaramide 
• 1032470-80-6 N,N'-bis[4-(5-3,4-butene-1,2,4-oxadiazol-3yl)phenyl]pentanediamide 
• 1032470-87-3 N,N'-bis[4-(N-oxycarboxymethylamidino)phenyl]pentanediamide 
• 1032470-72-6 N¹,N⁵-bis[4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]glutaramide 

Relevant articles and documents

Alkanediamide-linked bisbenzamidines are promising antiparasitic agents

A series of 15 alkanediamide-linked bisbenzamidines and related analogs was synthesized and tested in vitro against two Trypanosoma brucei (T.b.) subspecies: T.b. brucei and T.b. rhodesiense, Trypanosoma cruzi, Leishmania donovani and two Plasmodium falci

Design and synthesis of N1,N5-bis[4-(5-Alkyl-1,2,4- oxadiazol-3-yl)phenyl]glutaramides as potential antifungal prodrugs

A facile three step synthesis of a group of N1,N 5-bis[4-(5-alkyl-1,2,4-oxadiazol-3-yl)phenyl]glutaramides, N1,N 5-bis[4-(1,2,4-oxadiazol-3-yl)phenyl]glutaramide and N 1,N5-bis[4-(5-oxo-4,5-dihydro-1,

Synthesis and SAR of alkanediamide-linked bisbenzamidines with anti-trypanosomal and anti-pneumocystis activity

A series of alkanediamide-linked bisbenzamidines was synthesized and tested in vitro against a drug-sensitive strain of Trypanosoma brucei brucei, a drug-resistant strain of Trypanosoma brucei rhodesiense and Pneumocystis carinii. Bisbenzamidines linked w

Bisbenzamidines and bisbenzamidoximes for the treatment of human African trypanosomiasis

Disclosed are bisbenzamidine and bisbenzamidoxime compounds useful for treatment of treatment of trypanosomiasis. The compounds disclosed are useful for treating mammals infected with parasitic hemoflagellates, in particular Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense.